Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies

DOI:10.1021/acs.jmedchem.1c02148
作者：Ying Huang,?Martin Sendzik,?Jeff Zhang,?Zhenting Gao,?Yongfeng Sun,?Long Wang,?Justin Gu,?Kehao Zhao,?Zhengtian Yu,?Lijun Zhang,?Qiong Zhang,?Joachim Blanz,?Zijun Chen,?Valérie Dubost,?Douglas Fang,?
文献类型：期刊论文
补充材料：只需要正文